View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
July 23, 2021updated 22 Jul 2021 4:41pm

Covid-19: efforts and initiatives to end global vaccine inequity

Pharmaceutical Technology takes a look at some of the most recent efforts made to get more shots into arms worldwide.

By Darcy Jimenez

The race to inoculate the global population against Covid-19 is well underway, with almost four million vaccine doses having been administered worldwide so far. While a number of countries have fully vaccinated large swathes of their populations, some low-income nations are yet to administer a single dose.

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

As the debate over vaccine patent waivers continues, organisations and wealthy nations around the globe are helping to get shots into the arms of the world’s poorest through donations and other sharing initiatives.

Pharmaceutical Technology takes a look at some of the most recent efforts made to tackle vaccine inequity in disadvantaged countries.

Pfizer to provide vaccines to Africa through Biovac partnership

Pfizer and BioNTech have signed a letter of intent with South African biopharmaceutical company The Biovac Institute to produce their Covid-19 vaccine for distribution throughout the African Union’s 55 member states.

Under the agreement, Biovac will perform production and distribution activities within Pfizer and BioNTech’s global Covid-19 vaccine supply chain and manufacturing network, which will now span three continents and include more than 20 manufacturing facilities.

Biovac’s Cape Town facility is expected to be incorporated into the vaccine supply chain by the end of 2021, and the manufacturing of finished doses will commence in 2022.

US donates additional vaccine doses to Vietnam

The US Government has donated a further three million Covid-19 vaccine doses to Vietnam, bringing the total number of doses donated to the Southeast Asian country to five million.

The batch is expected to reach Vietnam this weekend (24-25 July), as part of President Joe Biden’s pledge to donate 80 million vaccine doses from the US’ domestic supply to countries around the world.

Africa to receive 25 million vaccine doses from US Government

A collaboration between the African Union (AU)’s African Vaccine Acquisition Trust, COVAX and the US Government will see African countries receive approximately 25 million Covid-19 vaccines.

The first shipments will deliver nearly a million doses of the Johnson & Johnson vaccine to Burkina Faso, Djibouti and Ethiopia.

A total of around 25 million doses of Covid-19 vaccines will be made available to 49 African countries in the coming weeks, in efforts to help the AU reach its goal of vaccinating at least 60% of the continent’s population.

CEPI launches COVAX ‘marketplace’ to enhance vaccine production

The Coalition for Epidemic Preparedness Innovations (CEPI) and COVAX partners have launched a ‘marketplace’ to accelerate the global production of Covid-19 vaccine doses for the COVAX scheme, aimed at achieving equitable access to Covid-19 vaccines worldwide.

The marketplace facilitates access to the supplies required for Covid-19 vaccines by matching suppliers with manufacturers who need them to produce jabs for distribution through COVAX. The initiative provides a secure platform for vaccine manufacturers and suppliers of critical materials to indicate their needs or available supplies to CEPI confidentially.

CEPI will prioritise matches based on objective criteria, including whether the manufacturer has a COVAX advance purchase agreement and World Health Organization emergency use listing in place, as well as dose volumes and delivery timings.

Related Companies

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology